Del Tacca M - Search Results

1

Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Macchiarini P, Della Torre P, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Toxicology. 1991;70(2):243-53. doi: 10.1016/0300-483x(91)90050-b. Toxicology. 1991. PMID: 1763418

2

Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart.

Bernardini N, Danesi R, Bernardini MC, Del Tacca M. Bernardini N, et al. Among authors: del tacca m. Experientia. 1988 Dec 1;44(11-12):1000-2. doi: 10.1007/BF01939901. Experientia. 1988. PMID: 3197802

3

Cytofluorescence localization and disposition of doxorubicin and doxorubicinol in rat cardiac tissue.

Danesi R, Paparelli A, Bernardini N, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1123-31. doi: 10.1016/0277-5379(88)90118-6. Eur J Cancer Clin Oncol. 1988. PMID: 3416897

4

Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.

Pinna A, Agen C, Di Paolo A, Innocenti F, Nardini D, Danesi R, Del Tacca M. Pinna A, et al. Among authors: del tacca m. J Environ Pathol Toxicol Oncol. 1994;13(1):25-31. J Environ Pathol Toxicol Oncol. 1994. PMID: 7823290

5

3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity.

Danesi R, Agen C, Grandi M, Nardini V, Bevilacqua G, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Eur J Cancer. 1993;29A(11):1560-5. doi: 10.1016/0959-8049(93)90295-q. Eur J Cancer. 1993. PMID: 8217363

6

Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart.

Agen C, Sironi AM, Danesi R, Costa M, Bernardini N, Paparelli A, Della Torre P, Del Tacca M. Agen C, et al. Among authors: del tacca m. Toxicology. 1992 Nov 15;75(3):209-19. doi: 10.1016/0300-483x(92)90003-w. Toxicology. 1992. PMID: 1455430

7

Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Zaccaro L, Pieracci D, Malvaldi G, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Cancer Chemother Pharmacol. 1992;29(4):261-5. doi: 10.1007/BF00685942. Cancer Chemother Pharmacol. 1992. PMID: 1472260

8

Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.

Bernardini N, Agen C, Favilla S, Danesi R, Del Tacca M. Bernardini N, et al. Among authors: del tacca m. J Endocrinol Invest. 1992 Feb;15(2):79-84. doi: 10.1007/BF03348668. J Endocrinol Invest. 1992. PMID: 1533234

9

Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.

Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Among authors: del tacca m. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601

10

Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol.

Danesi R, Marchetti A, Bernardini N, La Rocca RV, Bevilacqua G, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Cancer Chemother Pharmacol. 1990;26(6):403-8. doi: 10.1007/BF02994089. Cancer Chemother Pharmacol. 1990. PMID: 2171795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters